Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Tanabe

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Respiratory Medicine|June 30, 2023
Differential impacts between fat mass index and fat-free mass index on patients with COPDTakashi Shimada, Shotaro Chubachi, Shiro Otake, et al.
BMC Pulmonary Medicine|June 8, 2023
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, et al.
Respiratory Medicine|May 22, 2025
Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysemaFumi Mochizuki, Naoya Tanabe, Hiroaki Iijima, et al.
Respiratory Investigation|May 17, 2025
Exploring factors associated with clinical remission in patients with severe asthma receiving anti-IL-4Rα, anti-IL-5/5R, or anti-IgE treatmentShota Takahashi, Naoya Tanabe, Satoshi Marumo, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2021
Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunctionAsami Sukeishi, Kotaro Itohara, Atsushi Yonezawa, et al.
Chest|February 3, 2023
Stronger Associations of Centrilobular Than Paraseptal Emphysema With Longitudinal Changes in Diffusing Capacity and Mortality in COPDYusuke Shiraishi, Naoya Tanabe, Kaoruko Shimizu, et al.
Respirology (Carlton, Vic.)|June 26, 2024
Computed tomography mucus plugs and airway tree structure in patients with chronic obstructive pulmonary disease: Associations with airflow limitation, health-related independence and mortalityNaoya Tanabe, Kaoruko Shimizu, Hiroshi Shima, et al.
Respiratory Research|July 11, 2018
A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosisJohn E McDonough, Dries S Martens, Naoya Tanabe, et al.
ERJ Open Research|October 28, 2021
The importance of central airway dilatation in patients with bronchiolitis obliteransMariko Kogo, Hisako Matsumoto, Naoya Tanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 22, 2023
Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case seriesAsami Nishikawa, Isao Ito, Atsushi Yonezawa, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Respiratory Medicine|June 30, 2023
Differential impacts between fat mass index and fat-free mass index on patients with COPDTakashi Shimada, Shotaro Chubachi, Shiro Otake, et al.
BMC Pulmonary Medicine|June 8, 2023
An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)Kazuya Ichikado, Hidenori Ichiyasu, Kazuhiro Iyonaga, et al.
Respiratory Medicine|May 22, 2025
Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysemaFumi Mochizuki, Naoya Tanabe, Hiroaki Iijima, et al.
Respiratory Investigation|May 17, 2025
Exploring factors associated with clinical remission in patients with severe asthma receiving anti-IL-4Rα, anti-IL-5/5R, or anti-IgE treatmentShota Takahashi, Naoya Tanabe, Satoshi Marumo, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 18, 2021
Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunctionAsami Sukeishi, Kotaro Itohara, Atsushi Yonezawa, et al.
Chest|February 3, 2023
Stronger Associations of Centrilobular Than Paraseptal Emphysema With Longitudinal Changes in Diffusing Capacity and Mortality in COPDYusuke Shiraishi, Naoya Tanabe, Kaoruko Shimizu, et al.
Respirology (Carlton, Vic.)|June 26, 2024
Computed tomography mucus plugs and airway tree structure in patients with chronic obstructive pulmonary disease: Associations with airflow limitation, health-related independence and mortalityNaoya Tanabe, Kaoruko Shimizu, Hiroshi Shima, et al.
Respiratory Research|July 11, 2018
A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosisJohn E McDonough, Dries S Martens, Naoya Tanabe, et al.
ERJ Open Research|October 28, 2021
The importance of central airway dilatation in patients with bronchiolitis obliteransMariko Kogo, Hisako Matsumoto, Naoya Tanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 22, 2023
Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case seriesAsami Nishikawa, Isao Ito, Atsushi Yonezawa, et al.
Pageof 18